Mikaris 500mg Injection
Marketer
Azaris Pharma
Salt Composition
Amikacin (500mg)
Overview Mikaris 500mg Injection
Cefazolin 500mg injection is a broad-spectrum antibiotic combating diverse bacterial infections. These encompass urinary tract, bone, joint, lung (including pneumonia), brain, and bloodstream infections. Prophylactic use is common in hospitalized patients. Cefazolin inhibits bacterial growth. Administration, via intravenous infusion or direct injection (intravenous or intramuscular), requires healthcare professional supervision; self-injection is prohibited. Consistent dosing, as directed, is crucial. Complete the prescribed course, regardless of symptom improvement; premature cessation risks relapse or intensified infection. Common adverse effects include injection site reactions and elevated blood urea nitrogen. Persistent side effects or treatment ineffectiveness warrant immediate medical attention. High dosages may rarely cause vertigo, nephrotoxicity, and ototoxicity. Adhere strictly to your physician's instructions; regular kidney function, hearing, and urinalysis may be conducted. This antibiotic is contraindicated during pregnancy. Disclose pregnancy, pregnancy plans, or breastfeeding to your doctor.
Primary Ingredients of Mikaris 500mg Injection
The provided text is "undefined," therefore, no rephrasing is possible.
Uses of Mikaris 500mg Injection
Infections caused by bacteria
Major Benefits of Mikaris 500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Mikaris 500mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Mikaris 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Mikaris 500mg Injection works:
Mikaris 500mg injectable solution is a bacterial growth inhibitor. Its antibiotic action arises from disrupting the production of vital bacterial proteins, thereby halting essential cellular processes.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of Mikaris 500mg Injection and alcohol.
PregnancyCONSULT YOUR DOCTOR
Administering Mikaris 500mg Injection during pregnancy poses a confirmed risk to the fetus. Its use is contraindicated except in potentially life-threatening circumstances where a physician deems the potential benefits outweigh the inherent dangers. Medical guidance is essential.
Breast feedingSAFE IF PRESCRIBED
Administering Mikaris 500mg Injection while breastfeeding is considered safe. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
The administration of Mikaris 500mg Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if such effects are experienced.
KidneyCAUTION
For individuals with impaired kidney function, administering Mikaris 500mg Injection requires careful consideration. The prescribed dosage of Mikaris 500mg Injection might require modification. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Mikaris 500mg Injection appears to be well-tolerated in individuals with hepatic impairment. Preliminary findings indicate dose modification may not be necessary for this patient population. Physician consultation is recommended.
What if you forget to take Mikaris 500mg Injection :
Should you forget a scheduled dose of Mikaris 500mg Injection, seek advice from your physician.
Facts to Know About Mikaris 500mg Injection
| Label | Value |
|---|---|
| Type of Compound | Amino glycoside antibiotics |
| Potential for Dependence | None. |
| Medication Category | Agents against infection |
| Mechanism of Action | Amino glycosides |
3,018 People bought this recently